Paige offers cancer diagnostics with generative AI technologies, empowering hospitals and labs worldwide. It provides AI-driven tools that improve pathologists’ precision, streamline workflows, and digitize pathology laboratories. Its platform reduces diagnosis time, minimizes errors, and improves patient care through actionable insights. With a strong focus on interoperability and scalability, it enables accurate cancer detection and supporting clinicians.
📋 Overview of Paige
📙 About Paige
💰 Recent Investors of Paige
Casdin Capital, Catalio Capital Management, Investor
© 2025 Bot Memo. All Rights Reserved.
